122 related articles for article (PubMed ID: 15288732)
1. Diuretics in the LIFE study.
Kato J; Eto T
Lancet; 2004 Jul 31-Aug 6; 364(9432):413; author reply 413-4. PubMed ID: 15288732
[No Abstract] [Full Text] [Related]
2. [To protect the hypertensive patient from complications. Blood pressure lowering is not equal to blood pressure lowering].
MMW Fortschr Med; 2003 Nov; 145(45):51. PubMed ID: 14712789
[No Abstract] [Full Text] [Related]
3. [Plus point -- risk reduction].
MMW Fortschr Med; 2006 Aug; 148(33-34):56-7. PubMed ID: 16981392
[No Abstract] [Full Text] [Related]
4. [Therapy of hypertension in patients with atrial fibrillation. Sartan is superior to beta-blocker].
MMW Fortschr Med; 2003 May; 145(19):53. PubMed ID: 12813983
[No Abstract] [Full Text] [Related]
5. Pulse pressure and antihypertensive agents.
Safar ME; O'Rourke MF
Hypertension; 2005 Aug; 46(2):e6; author reply e6-7. PubMed ID: 16027242
[No Abstract] [Full Text] [Related]
6. Potential mechanisms of stroke benefit favoring losartan in the Losartan Intervention For Endpoint reduction in hypertension (LIFE) study.
Devereux RB; Dahlöf B
Curr Med Res Opin; 2007 Feb; 23(2):443-57. PubMed ID: 17288698
[TBL] [Abstract][Full Text] [Related]
7. Losartan for cardiovascular disease in patient's with and without diabetes in the LIFE study.
Fuchs FD
Lancet; 2002 Jun; 359(9324):2203; author reply 2203-4. PubMed ID: 12091010
[No Abstract] [Full Text] [Related]
8. Blood pressure reduction and antihypertensive medication use in the losartan intervention for endpoint reduction in hypertension (LIFE) study in patients with hypertension and left ventricular hypertrophy.
Devereux RB; de Faire U; Fyhrquist F; Harris KE; Ibsen H; Kjeldsen SE; Lederballe-Pedersen O; Lindholm LH; Nieminen MS; Omvik P; Oparil S; Wedel H; Hille DA; Dahlöf B
Curr Med Res Opin; 2007 Feb; 23(2):259-70. PubMed ID: 17288679
[TBL] [Abstract][Full Text] [Related]
9. [German Hypertension League on the LIFE Study. New evaluation of AT1 receptor antagonists].
Dominiak P; Zidek W
MMW Fortschr Med; 2002 Sep; 144(38):47. PubMed ID: 12395703
[No Abstract] [Full Text] [Related]
10. [What are the consequences of the LIFE Study for general practice].
Zidek W
MMW Fortschr Med; 2002 Sep; 144(38):48. PubMed ID: 12395704
[No Abstract] [Full Text] [Related]
11. [LIFE study proves preventive action. With losartan to do even more against stroke].
Baumgart P
MMW Fortschr Med; 2003; 145 Suppl 1():7-8. PubMed ID: 12958796
[No Abstract] [Full Text] [Related]
12. [Isolated systolic hypertension. "AT1 blocker preferred over beta-blocker"].
MMW Fortschr Med; 2002 Sep; 144(38):14. PubMed ID: 12395694
[No Abstract] [Full Text] [Related]
13. [Fewer cases of stroke, atrial fibrillation, diabetes and renal insufficiency. Good treatment of hypertension is more than lowering of blood pressure].
Baumgart P
MMW Fortschr Med; 2008 Jan; 150(1-2):52-3. PubMed ID: 18300647
[No Abstract] [Full Text] [Related]
14. The LIFE Trial in 2004.
Beevers DG
J Hum Hypertens; 2004 Jun; 18(6):365. PubMed ID: 15153931
[No Abstract] [Full Text] [Related]
15. [Results from the LIFE study: promising effects of new hypertensive agents].
Nilsson P; Kahan T
Lakartidningen; 2002 Apr; 99(16):1792-4. PubMed ID: 12043477
[No Abstract] [Full Text] [Related]
16. Losartan vs atenolol in prevention of stroke and cardiovascular disease.
Fournier A; Oprisiu R; Andrejak M; Fernandez L; Achard JM
JAMA; 2003 Feb; 289(6):700; author reply 701. PubMed ID: 12585946
[No Abstract] [Full Text] [Related]
17. Losartan vs atenolol in prevention of stroke and cardiovascular disease.
Messerli FH; Grossman E; Fournier A
JAMA; 2003 Feb; 289(6):700-1; author reply 701. PubMed ID: 12585945
[No Abstract] [Full Text] [Related]
18. [When compliance doesn't work out. Calculate the risk of stroke for hypertensive patients!].
MMW Fortschr Med; 2004 Feb; 146(7):61. PubMed ID: 15347060
[No Abstract] [Full Text] [Related]
19. Angiotensin II inhibition and prevention of atrial fibrillation and stroke.
Bourassa MG
J Am Coll Cardiol; 2005 Mar; 45(5):720-1. PubMed ID: 15734616
[No Abstract] [Full Text] [Related]
20. The effect of losartan compared with atenolol on the incidence of revascularization in patients with hypertension and electrocardiographic left ventricular hypertrophy. The LIFE study.
Olsen MH; Wachtell K; Dahlöf B; Devereux RB; Ibsen H; Kjeldsen SE; Lindholm LH; Lyle PA; Nieminen MS
J Hum Hypertens; 2006 Jun; 20(6):460-4. PubMed ID: 16572193
[No Abstract] [Full Text] [Related]
[Next] [New Search]